|
NXT2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
3.66373598126302E-15 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
5.534000E-01 |
| Stage1-vs-Stage3 |
8.557400E-01 |
| Stage1-vs-Stage4 |
3.402200E-03 |
| Stage2-vs-Stage3 |
7.115800E-01 |
| Stage2-vs-Stage4 |
8.166000E-02 |
| Stage3-vs-Stage4 |
2.137600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
6.3053007259839E-11 |
| Normal-vs-Asian |
1.63080660087189E-12 |
| Caucasian-vs-AfricanAmerican |
7.127400E-01 |
| Caucasian-vs-Asian |
8.133400E-01 |
| AfricanAmerican-vs-Asian |
8.711200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
1.322330E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.431020E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.487800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.620800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.506200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.773200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.050800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.969000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.221200E-01 |
| Classical-VS-Follicular |
2.922000E-01 |
| Classical-VS-Other |
3.452400E-01 |
| Classical-VS-Normal |
4.44089209850063E-16 |
| Tall-VS-Follicular |
1.723010E-01 |
| Tall-VS-Other |
2.491200E-01 |
| Tall-VS-Normal |
2.47580000944936E-09 |
| Follicular-VS-Other |
6.509400E-01 |
| Follicular-VS-Normal |
1.62447832963153E-12 |
| Other-VS-Normal |
1.63636999999106E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
2.389400E-01 |
|
|
